Author

Anisha B. Tehim

Cornell University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Ekta KhuranaiD· 2 shared Marjorie L. RoskesiD· 2 shared Yu CheniD· 2 shared Alexander Martinez‐FundichelyiD· 1 shared Ana Molina· 1 shared Andrea SboneriD· 1 shared Anuradha GopalaniD· 1 shared Benjamin J. RaphaeliD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Ekta KhuranaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintJul 1, 2025

Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancer

Marjorie L. Roskes, Alexander Martinez‐Fundichely, Sandra M. Cohen…·Ekta Khurana

The paper identifies genomic alterations in the YAP/TAZ pathway associated with stem cell-like castration-resistant prostate cancer using transcriptomic and whole-genome sequencing data.

DOI 10.1101/2025.07.01.25330467

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyJournal of Clinical InvestigationPeer-reviewedJun 24, 2025

BET inhibitors as a therapeutic intervention in gastrointestinal gene signature-positive castration-resistant prostate cancer.

Shipra Shukla, Dan Li, Woo Hyun Cho…·Yu Chen

This study identifies BET inhibitors as effective against GI transcriptome-positive CRPC by targeting HNF1A and HNF4G, improving outcomes in preclinical models.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky